BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37004910)

  • 1. Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein.
    Ji A; Trumbauer AC; Noffsinger VP; de Beer FC; Webb NR; Tannock LR; Shridas P
    J Lipid Res; 2023 May; 64(5):100365. PubMed ID: 37004910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.
    De Beer MC; Wroblewski JM; Noffsinger VP; Rateri DL; Howatt DA; Balakrishnan A; Ji A; Shridas P; Thompson JC; van der Westhuyzen DR; Tannock LR; Daugherty A; Webb NR; De Beer FC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):255-61. PubMed ID: 24265416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
    de Vries-van der Weij J; Zadelaar S; Toet K; Havekes LM; Kooistra T; Rensen PC
    Atherosclerosis; 2009 Sep; 206(1):153-8. PubMed ID: 19345354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A3 is pro-atherogenic.
    Thompson JC; Wilson PG; Shridas P; Ji A; de Beer M; de Beer FC; Webb NR; Tannock LR
    Atherosclerosis; 2018 Jan; 268():32-35. PubMed ID: 29175652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice.
    Hirata H; Yimin ; Segawa S; Ozaki M; Kobayashi N; Shigyo T; Chiba H
    PLoS One; 2012; 7(11):e49415. PubMed ID: 23166663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.
    Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1105-10. PubMed ID: 10195942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Amyloid A Is an Exchangeable Apolipoprotein.
    Wilson PG; Thompson JC; Shridas P; McNamara PJ; de Beer MC; de Beer FC; Webb NR; Tannock LR
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1890-1900. PubMed ID: 29976766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice.
    Jongejan YK; Eikenboom JCJ; Gijbels MJJ; Berbée JFP; van Vlijmen BJM
    J Thromb Thrombolysis; 2021 Oct; 52(3):715-719. PubMed ID: 34052976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein.
    Kinoshita M; Arai H; Fukasawa M; Watanabe T; Tsukamoto K; Hashimoto Y; Inoue K; Kurokawa K; Teramoto T
    J Lipid Res; 1993 Feb; 34(2):261-8. PubMed ID: 8429260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice.
    Ahlin S; Olsson M; Wilhelmson AS; Skålén K; Borén J; Carlsson LM; Svensson PA; Sjöholm K
    PLoS One; 2014; 9(4):e95468. PubMed ID: 24751653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis].
    Mao MJ; Hu JP; Chen FR; Zhang YY; Liu P
    Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):306-12. PubMed ID: 21419084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated atherosclerosis caused by serum amyloid A response in lungs of ApoE
    Christophersen DV; Møller P; Thomsen MB; Lykkesfeldt J; Loft S; Wallin H; Vogel U; Jacobsen NR
    FASEB J; 2021 Mar; 35(3):e21307. PubMed ID: 33638910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
    van der Hoorn JW; Jukema JW; Havekes LM; Lundholm E; Camejo G; Rensen PC; Princen HM
    Br J Pharmacol; 2009 Apr; 156(7):1067-75. PubMed ID: 19220285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I stimulates cholesteryl ester transfer protein and apolipoprotein E secretion from lipid-loaded macrophages; the role of NF-κB and PKA signaling pathways.
    Niculescu LS; Robciuc MR; Sanda GM; Sima AV
    Biochem Biophys Res Commun; 2011 Nov; 415(3):497-502. PubMed ID: 22056562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia.
    Fazio S; Marotti KR; Lee YL; Castle CK; Melchior GW; Rall SC
    J Biol Chem; 1994 Dec; 269(51):32368-72. PubMed ID: 7798236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
    Harder C; Lau P; Meng A; Whitman SC; McPherson R
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.